Search results
Results from the WOW.Com Content Network
In 1979 a new edition was published with a new title, The Pharmaceutical Codex. The Medicines Commission had recommended in 1972 that the British Pharmacopoeia should henceforth be the only compendium of official standards for medicines in the UK, and the BPC lost its status as an official book. The PSGB remained as the publishers.
The British Pharmacopoeia (BP) is the national pharmacopoeia of the United Kingdom.It is an annually published collection of quality standards for medicinal substances in the UK, which is used by individuals and organisations involved in pharmaceutical research, development, manufacture and testing.
The Commission on Human Medicines (CHM) is a committee of the UK's Medicines and Healthcare products Regulatory Agency.It was formed in October 2005, and assumed the responsibilities of the Medicines Commission and the Committee on Safety of Medicines.
Martindale Pharma – Martindale Pharmaceuticals - Ltd (Now Ethypharm UK) Mölnlycke – Mölnlycke Health Care Ltd; Mayne – Mayne Pharma plc; McNeil – McNeil Laboratories Ltd; Meda – Meda Pharmaceuticals Ltd; Medac – Medac (UK), Scion House, University of Stirling; MediSense – MediSense, Abbott Laboratories Ltd; Menarini – A ...
A British Approved Name (BAN) is the official, non-proprietary, or generic name given to a pharmaceutical substance, as defined in the British Pharmacopoeia (BP). [1] The BAN is also the official name used in some countries around the world, because starting in 1953, proposed new names were evaluated by a panel of experts from WHO in conjunction with the BP commission to ensure naming ...
The Association of the British Pharmaceutical Industry (ABPI) is the trade association for over 120 companies in the UK producing prescription medicines for humans, founded in 1891. [1] It is the British equivalent of America's PhRMA ; however, the member companies research, develop, manufacture and supply medicines prescribed for the National ...
The MHRA and the US Food and Drug Administration were criticised in the 2012 book Bad Pharma, [43] and in 2004 by David Healy in evidence to the House of Commons Health Committee, [44] for having undergone regulatory capture, i.e. advancing the interests of the drug companies rather than the interests of the public.
As a student, he was awarded medals in chemistry, botany and materia medica. He qualified as a pharmaceutical chemist in 1891, becoming a demonstrator in the Society's laboratory and school. He later became head of the analytical laboratory at Burroughs Wellcome, and assisted in the compilation of the British Pharmaceutical Codex.